Peng, Lang, Jiawen He, Ying Zheng, and Qingfang Zeng. 2025. “Effects of Monoclonal Antibody Daratumumab Combined With Ixazomib-Based Treatment Regimen on Survival of Patients With Relapsed Refractory Multiple Myeloma”. Vojnosanitetski Pregled 82 (04). https://doi.org/10.2298/VSP231207016P.